NM_006892.4(DNMT3B):c.1609C>T (p.Arg537Trp) AND Inborn genetic diseases
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- May 31, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003274202.2
Allele description [Variation Report for NM_006892.4(DNMT3B):c.1609C>T (p.Arg537Trp)]
NM_006892.4(DNMT3B):c.1609C>T (p.Arg537Trp)
Condition(s)
- Name:
- Inborn genetic diseases
- Identifiers:
- MeSH: D030342; MedGen: C0950123
-
Oncostatin M Receptor beta Subunit
Oncostatin M Receptor beta SubunitAn ONCOSTATIN M-specific receptor subunit that combines with CYTOKINE RECEPTOR GP130 to form the ONCOSTATIN M TYPE II RECEPTOR.<br/>Year introduced: 2007(2003)MeSH
-
Receptors, OSM-LIF
Receptors, OSM-LIFCell surface receptors formed from the dimerization of LIF RECEPTOR ALPHA SUBUNIT with CYTOKINE RECEPTOR GP130. Although originally described as receptors for LEUKEMIA INHIBIT...<br/>Year introduced: 2007(1991)MeSH
-
Heterogeneous-Nuclear Ribonucleoprotein Group M
Heterogeneous-Nuclear Ribonucleoprotein Group MA group of closely-related 72-74-kDa heterogeneous-nuclear ribonucleoproteins that are involved in RNA SPLICING events.<br/>Year introduced: 2003MeSH
-
Apolipoproteins M
Apolipoproteins MApolipoproteins and lipocalins that occur in HIGH-DENSITY LIPOPROTEINS. They bind or transport lipids in the blood including sphingosine-1-phosphate, MYRISTIC ACID; STEARIC AC...<br/>Year introduced: 2018MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024